E. Rolland Dickson
Voorzitter bij Sigismunda Charitable Foundation
Oorsprong van het eerstegraads netwerk van E. Rolland Dickson
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 24 | |
| Subsidiary | Agricultural Commodities/Milling | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met E. Rolland Dickson via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | General Counsel | |
BioTransplant, Inc.
 BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA. | Pharmaceuticals: Major | Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| FIBROCELL SCIENCE, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| IMUNON, INC. | Biotechnology | Director of Finance/CFO | |
| ARROWHEAD PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member | |
| APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Trinity University | College/University | Undergraduate Degree | |
| SCOLR PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| MONSANTO | Wholesale Distributors | Corporate Officer/Principal Corporate Officer/Principal | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| LIMINAL BIOSCIENCES INC. | Biotechnology | Director of Finance/CFO | |
| HUMANIGEN, INC. | Biotechnology | Chairman Director/Board Member | |
| ATOSSA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Miscellaneous Commercial Services | Chief Executive Officer | |
| ORYZON GENOMICS S.A. | Biotechnology | Director of Finance/CFO | |
| Boston College | College/University | Masters Business Admin | |
| University of Guelph | College/University | Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Director/Board Member | |
| University of California, Davis | College/University | Doctorate Degree Doctorate Degree | |
| University of Maryland | College/University | Graduate Degree Undergraduate Degree | |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Investment Managers | Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal Consultant / Advisor Private Equity Investor | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PLUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Biotechnology | Corporate Officer/Principal | |
| VIA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| XENO TRANSPLANTS CORPORATION | Biotechnology | Chairman | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Director/Board Member | |
Verity Solutions Group, Inc.
 Verity Solutions Group, Inc. Packaged SoftwareTechnology Services Verity Solutions Group, Inc. specializes in software and services developed for administration of the federal 340B drug pricing program. Its solutions include split billing, contract pharmacy, specialty contract pharmacy, audit & compliance services, compliance manager, purchase analytics and VHUB. The company was founded by James E. Torina in 2002 and is headquartered in Kirkland, WA. | Packaged Software | Director of Finance/CFO | |
Oncology, Inc.
 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Dentsu Group, Inc., Oncology, Inc. provides oncology treatment information. The company is based in Cherry Hill, NJ. Oncology was acquired by Aegis Group Plc on January 07, 2008. | Miscellaneous Commercial Services | Director of Finance/CFO | |
AVITA Medical Pty Ltd.
 AVITA Medical Pty Ltd. BiotechnologyHealth Technology Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company is headquartered in Valencia, CA. | Biotechnology | Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin Graduate Degree | |
Cetya Therapeutics, Inc.
 Cetya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cetya Therapeutics, Inc. engages in the commercialization of histone deacetylase inhibitors based on largazole. Its histone deacetylase inhibitors analog has bifunctional modifications and the potential to target specific cell types or tumors. The company was founded by John Pilon in 2012 and is headquartered in Fort Collins, Co. | Pharmaceuticals: Major | Director/Board Member Founder | |
Nuvelution Pharma, Inc.
 Nuvelution Pharma, Inc. BiotechnologyHealth Technology Nuvelution Pharma, Inc. provides solutions for R&D companies in the pharmaceutical and biotech industries. The firm leverages its knowledge, experience and relationships in the Pharma and Biotech industries to deploy capital in risk-sharing collaborations with companies where product development can be facilitated by both capital and human resources, making this model an essential tool for pharma and biotech companies to bring products to the market. The company was founded by Sanford S. Zweifach and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer Director/Board Member | |
| ELOXX PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO | |
| Kalobios Pharmaceuticals, Inc. | Chairman Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 44 |
| Canada | 5 |
| Zwitserland | 2 |
| Spanje | 2 |
| Israël | 2 |
Sectoraal
| Health Technology | 33 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Technology Services | 3 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 207 |
| Corporate Officer/Principal | 70 |
| Independent Dir/Board Member | 63 |
| Chairman | 38 |
| President | 35 |
Sterkste connecties
| Insiders | |
|---|---|
| Elaine Chao | 40 |
| Douglass Given | 35 |
| Nicholas Simon | 33 |
| Carl Goldfischer | 31 |
| Michael Perry | 28 |
| Sherry Lansing | 25 |
| Gregory Weaver | 22 |
| Gary Lyons | 20 |
| Dennis Mark Weinberg | 20 |
| Caroline Loewy | 17 |
| Ronald Martell | 16 |
| Robert S. Basso | 15 |
| David Stevens | 15 |
| Gerald McMahon | 13 |
| Richard Ghalie | 13 |
- Beurs
- Insiders
- E. Rolland Dickson
- Bedrijfsconnecties
